alexa Abstract | Evaluation of in vitro anticancer activity of Terminalia chebula and Identification of Phytocompounds by GC MS analysis

Journal of Chemical and Pharmaceutical Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Original Articles Open Access


The present study was aimed to evaluate the potential of the ethanolic extract of Terminalia chebula in mitigating breast cancer, which is crippling several women around the world. We have identified the phytochemicals and confirmed by GC-MS studies. Further investigations were carried out to determine the anticancer activity of the extract invitro by MTT assay and antioxidant activity by Reducing Power assay. The results obtained were found to be effective in authenticating the pharmacological nature of T. chebula. In this effort, we have surfaced with a promising potential therapeutic agent as a part of our research work. Our observations are suggestive of the fact that this extract could ably serve as a drug candidate for further research, being a harbinger of hope to cancer patients

To read the full article Peer-reviewed Article PDF image

Author(s): Deena Priscilla H and Jasmine R


Breast cancer, Terminalia chebula, MTT assay, GC-MS, Antioxidant, anticancer

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version